JP2023539695A5 - - Google Patents

Info

Publication number
JP2023539695A5
JP2023539695A5 JP2023537724A JP2023537724A JP2023539695A5 JP 2023539695 A5 JP2023539695 A5 JP 2023539695A5 JP 2023537724 A JP2023537724 A JP 2023537724A JP 2023537724 A JP2023537724 A JP 2023537724A JP 2023539695 A5 JP2023539695 A5 JP 2023539695A5
Authority
JP
Japan
Prior art keywords
acrylamide
indazole
alkyl
alkylene
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023537724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539695A (ja
JP7784431B2 (ja
Filing date
Publication date
Priority claimed from GBGB2013731.1A external-priority patent/GB202013731D0/en
Application filed filed Critical
Publication of JP2023539695A publication Critical patent/JP2023539695A/ja
Publication of JP2023539695A5 publication Critical patent/JP2023539695A5/ja
Application granted granted Critical
Publication of JP7784431B2 publication Critical patent/JP7784431B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023537724A 2020-09-01 2021-09-01 新規化合物 Active JP7784431B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2013731.1A GB202013731D0 (en) 2020-09-01 2020-09-01 Novel cmpounds
GB2013731.1 2020-09-01
PCT/GB2021/052262 WO2022049377A1 (en) 2020-09-01 2021-09-01 Novel compounds

Publications (3)

Publication Number Publication Date
JP2023539695A JP2023539695A (ja) 2023-09-15
JP2023539695A5 true JP2023539695A5 (cg-RX-API-DMAC7.html) 2024-09-11
JP7784431B2 JP7784431B2 (ja) 2025-12-11

Family

ID=72749727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023537724A Active JP7784431B2 (ja) 2020-09-01 2021-09-01 新規化合物

Country Status (9)

Country Link
US (1) US12497359B2 (cg-RX-API-DMAC7.html)
EP (1) EP4208448B1 (cg-RX-API-DMAC7.html)
JP (1) JP7784431B2 (cg-RX-API-DMAC7.html)
CN (1) CN116096712B (cg-RX-API-DMAC7.html)
AU (1) AU2021336750A1 (cg-RX-API-DMAC7.html)
CA (1) CA3190786A1 (cg-RX-API-DMAC7.html)
GB (1) GB202013731D0 (cg-RX-API-DMAC7.html)
IL (1) IL300904A (cg-RX-API-DMAC7.html)
WO (1) WO2022049377A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202013728D0 (en) 2020-09-01 2020-10-14 Nrg Therapeutics Ltd Novel compounds
GB202300833D0 (en) 2023-01-19 2023-03-08 Nrg Therapeutics Ltd Novel compounds
CN121866248A (zh) 2023-09-05 2026-04-14 Nrg治疗有限公司 作为mptp抑制剂起作用的吡啶衍生物
CN118255724A (zh) * 2024-03-27 2024-06-28 河北天成药业股份有限公司 盐酸利多卡因杂质的合成方法及其反应检测方法
GB202410534D0 (en) 2024-07-18 2024-09-04 Nrg Therapeutics Ltd Novel method and uses
CN120025281A (zh) * 2025-04-22 2025-05-23 九洲药业(杭州)有限公司 一种n,n-二异丁基-1h-吲唑-4-胺的中间体及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003020313A1 (ja) 2001-09-04 2004-12-16 小野薬品工業株式会社 スフィンゴシン−1−リン酸受容体調節剤からなる呼吸器疾患治療剤
AU2002354476A1 (en) 2001-12-14 2003-06-30 Japan Tobacco Inc. Pyrazolopyridine derivatives and medicinal use thereof
JP2006512306A (ja) 2002-08-29 2006-04-13 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション アリール及びヘテロアリールプロペンアミド、それらの誘導体並びにそれらの治療用途
BRPI0619263A2 (pt) * 2005-11-30 2011-09-27 Hoffmann La Roche indóis de 3-amino-1-arilpropila e indóis aza-substituìdos, métodos para prepará-los, composição farmacêutica e uso dos referidos indóis
JP5495206B2 (ja) 2006-10-24 2014-05-21 コンジエニア・ソシエタ・ア・レスポンサビリタ・リミタータ 変性性組織障害をmptの阻害により防止するための薬剤としてのフェニル置換マレイミド
EP2179984A1 (en) * 2008-10-27 2010-04-28 Congenia S.r.l. Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
WO2011087051A1 (ja) 2010-01-14 2011-07-21 国立大学法人金沢大学 S1p2受容体アンタゴニストを含む粥状動脈硬化治療薬
JP2017538676A (ja) 2014-11-05 2017-12-28 ザ ユニバーシティ オブ カンザス ミトコンドリア透過性遷移孔(mtPTP)の小分子阻害剤
CA2884607A1 (en) 2015-03-11 2016-09-11 Stealth Peptides International, Inc. Therapeutic compositions including acrylamido compounds or phenyl-substiituted maleimide compounds and uses thereof to treat and prevent mitochondrial diseases and conditions
WO2019002624A1 (de) 2017-06-30 2019-01-03 Kleuser, Burkhard Mittel zur therapie entzündlicher darmerkrankungen
GB202013728D0 (en) * 2020-09-01 2020-10-14 Nrg Therapeutics Ltd Novel compounds

Similar Documents

Publication Publication Date Title
ES2538714T3 (es) Derivados de 2,4,5-trifenil-imidazolina como inhibidores de la interacción entre las proteínas p53 y MDM2 para el uso en calidad de agentes anticancerosos
ES2750655T3 (es) Derivados de pirrolo[2,3-d]pirimidina útiles para inhibir la Janus cinasa
ES2605565T3 (es) Compuestos de hexahidropirano [3,4-D][1,3]tiazin-2-amina
JP2023539694A5 (cg-RX-API-DMAC7.html)
PE20091444A1 (es) Derivados de isoxazolo-pirazina
HRP20201107T1 (hr) Heteroaril amidi kao inhibitori proteinske agregacije
JP2018115215A5 (cg-RX-API-DMAC7.html)
MA38272A1 (fr) Peptides en tant qu'agonistes de l'oxytocine
GEP20125621B (en) 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
ES2733502T3 (es) Compuestos de imidazopiridazina
AR076376A1 (es) Azetidinil diamidas como inhibidores de monoacilglicerol lipasa
JP2012523440A5 (cg-RX-API-DMAC7.html)
HRP20160253T1 (hr) Inhibitor benzodiazepinske bromodomene
JP2013010792A5 (cg-RX-API-DMAC7.html)
JP2017524742A (ja) テトラヒドロキノリン誘導体の調製のための合成中間体の調製方法
AU2013326850B2 (en) Novel compounds, their preparation and their uses
CA2971110A1 (en) 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis
JP2019535825A5 (cg-RX-API-DMAC7.html)
CA2758474A1 (en) Novel p2x7r antagonists and their use
MA38079A1 (fr) Composés de 2-phényl-5-hétérocyclyl-tétrahydro-2h-pyran-3-amine destinés à être utilisés dans le traitement du diabète et de ses troubles associés
MA38323B1 (fr) Dérivés pyrimidone et leur utilisation dans le traitement, l'amélioration ou la prévention d'une maladie virale
AR051290A1 (es) Derivados de hidantoina sustituidas
RU2018103332A (ru) Пиримидиновое соединение с конденсированными кольцами, его промежуточное соединение, способ получения, композиция и применение
JP2023509944A5 (cg-RX-API-DMAC7.html)
JP2024534111A5 (cg-RX-API-DMAC7.html)